BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23373446)

  • 1. The molecular biology of WHO grade II gliomas.
    Marko NF; Weil RJ
    Neurosurg Focus; 2013 Feb; 34(2):E1. PubMed ID: 23373446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of gliomas: from morphology to molecules.
    Ferris SP; Hofmann JW; Solomon DA; Perry A
    Virchows Arch; 2017 Aug; 471(2):257-269. PubMed ID: 28674742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
    Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC
    Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Occurrence and molecular pathology of low grade gliomas].
    Murnyák B; Csonka T; Klekner A; Hortobágyi T
    Ideggyogy Sz; 2013 Sep; 66(9-10):305-11. PubMed ID: 24358685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [OMICS and biomarkers of glial tumors].
    Idbaih A
    Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Histological classification of human gliomas: state of art and controversies].
    Figarella-Branger D; Bouvier C
    Bull Cancer; 2005 Apr; 92(4):301-9. PubMed ID: 15888386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic classification of gliomas.
    Perry A; Wesseling P
    Handb Clin Neurol; 2016; 134():71-95. PubMed ID: 26948349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecularly based management of gliomas in clinical practice.
    Rudà R; Pellerino A; Magistrello M; Franchino F; Pinessi L; Soffietti R
    Neurol Sci; 2015 Sep; 36(9):1551-7. PubMed ID: 26194534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole genome analysis from microdissected tissue revealed adult supratentorial grade II-III gliomas are divided into clinically relevant subgroups by genetic profile.
    Hirose Y; Sasaki H; Miwa T; Ohba S; Ikeda E; Abe M; Ikeda S; Kobayashi M; Kawase T; Hasegawa M; Yoshida K
    Neurosurgery; 2011 Aug; 69(2):376-90. PubMed ID: 21358357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign Glioma.
    Wu PB; Filley AC; Miller ML; Bruce JN
    Adv Exp Med Biol; 2023; 1405():31-71. PubMed ID: 37452934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Input of molecular analysis in medical management of primary brain tumor patients.
    Idbaih A; Duran-Peña A; Bonnet C; Ducray F
    Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric high grade gliomas: A comprehensive histopathological, immunohistochemical and molecular integrated approach in routine practice.
    Das S; Ahlawat S; Panda AK; Sarangi J; Jain P; Gupta RK; Vaishya S; Patir R
    Pathol Res Pract; 2024 Jun; 258():155347. PubMed ID: 38763090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Gliomas: Current Concepts on Diagnosis, Biology, and Clinical Management.
    Sturm D; Pfister SM; Jones DTW
    J Clin Oncol; 2017 Jul; 35(21):2370-2377. PubMed ID: 28640698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment.
    Rizzo D; Ruggiero A; Martini M; Rizzo V; Maurizi P; Riccardi R
    Biomed Res Int; 2015; 2015():215135. PubMed ID: 26448930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characteristics of pediatric high-grade gliomas.
    Chamdine O; Gajjar A
    CNS Oncol; 2014 Nov; 3(6):433-43. PubMed ID: 25438814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
    Nutt CL; Mani DR; Betensky RA; Tamayo P; Cairncross JG; Ladd C; Pohl U; Hartmann C; McLaughlin ME; Batchelor TT; Black PM; von Deimling A; Pomeroy SL; Golub TR; Louis DN
    Cancer Res; 2003 Apr; 63(7):1602-7. PubMed ID: 12670911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histomolecular classification of adult diffuse gliomas: the diagnostic value of immunohistochemical markers.
    Figarella-Branger D; Maues de Paula A; Colin C; Bouvier C
    Rev Neurol (Paris); 2011 Oct; 167(10):683-90. PubMed ID: 21889777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Occurrence and molecular pathology of high grade gliomas].
    Murnyák B; Csonka T; Hegyi K; Méhes G; Klekner A; Hortobágyi T
    Ideggyogy Sz; 2013 Sep; 66(9-10):312-21. PubMed ID: 24358686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.